Table 6 Antibiotic sensitivity of isolated Gram-negative pathogens from solid malignancy patients during BSI episodes
Gram-ve bacteria | Escherichia coli Sensitivity(UD) | Psuedomonas aeruginosa | Klebsiella spp. | Acinetobacter bumannii |
|---|---|---|---|---|
Antibiotics | ||||
Piperacillin-tazobactam | 95.2 | 83.3 | 50 (5.6) | 16.7 |
Ceftazidime | 47.6 | 66.7 | 55.6 (5.6) | 16.7 |
Cefepime | 47.6 | 66.7 | 55.6 (5.6) | 16.7 |
Imipenem | 100 | 50 (16.7) | 72.2 | 16.7 |
Meropenem | 100 | 66.7 (16.7) | 72.2 | 16.7 |
Gentamicin | 90.5 | 83.3 | 72.2 | 16.7 (33.3) |
Ciprofloxacin | 47.6 (4.8) | 66.7 | 55.6 (5.6) | 16.7 |
Trimethoprim-Sulfamethoxazole | 19 (47.6) | UD | 61.1 (11.1) | 50 |
Amikacin | 100 | 83.3 | 66.7 (11.1) | UD |
Ampicillin | 19 (9.5) | UD | 0 | UD |
Amoxicillin/clavulanic acid | 66.7 (19) | UD | 33.3 (11.1) | 0 (66.7) |
Cefotaxime | 42.9 (4.8) | UD | 50 (4.6) | UD |
Ceftriaxone | 42.9 (4.8) | UD | 55.6 | 0 (66.7) |
Levofloxacin | 4.8 (90.5) | UD | 5.6 (94.4) | 0 (50) |